Holding(s) in Company

| Filed in:
Tate & Lyle PLC ('the Company') was informed on 30 March 2006 that as at 29 March 2006 AXA S.A. together with its Group Companies has a notifiable interest in 70,427,276 ordinary shares of 25 pence each in the Company, being 14.43 per cent. of the Company's ordinary share capital (of which 43,975 shares represent a beneficial interest and 70,383,301 shares represent a non-beneficial interest). AXA S.A. had previously reported holding 78,451,332 ordinary shares in the Company as at 21 March 2006 in which they had a notifiable interest which was then 16.05 per cent. of the ordinary share capital.

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.